Last updated: July 6, 2026
Premasol 10% in plastic container is a 10% pharmaceutical solution packaged in a plastic container. Supply originates from the branded manufacturer and a network of contract manufacturers that produce the drug substance/solution, fill-finish in plastics, and provide distribution. Exact supplier identities depend on the market and the specific Premasol label/strength packaging SKU sold in that jurisdiction.
Who manufactures Premasol 10% in plastic container and which suppliers fill-finish it?
Featured snippet answer: Premasol 10% is supplied through manufacturer-distributor channels and contract fill-finish networks. The relevant suppliers are the brand owner (or authorized local marketing authorization holder) plus the contract manufacturers performing sterile or regulated production and plastic-container packaging.
What typically sits behind “plastic container” supply?
Premasol 10% packaged in plastic commonly implies one or more of these upstream supplier categories:
- Drug product manufacturer producing the premix/solution to the labeled concentration (10%)
- Sterile manufacturing and release testing partners (if the product is sterile)
- Packaging suppliers providing the plastic container system (bag/bottle-type) and closures
- Fill-finish partners performing aseptic filling (if applicable) and container sealing
- Logistics and regulatory release operations for distribution to hospitals and pharmacies
What supplier types matter for procurement and continuity?
For procurement, the practical supplier list usually breaks into:
- Marketing authorization holder or label owner (commercial supplier of record)
- Contract manufacturing organization (CMO) producing the solution
- Contract packager (often same entity as CMO) providing plastic-container filling/assembly
- Local distributor or import agent in the destination country
Which companies supply Premasol 10% to hospitals and pharmacies?
Featured snippet answer: Hospitals and pharmacies typically purchase Premasol 10% via the branded label holder or their authorized distributors; in parallel, some markets source through parallel distributors if permitted by local rules.
Hospital supply chain pattern
In hospital tenders, the winning supplier is usually:
- The authorized distributor of the marketing authorization holder, or
- A government-approved procurement entity, or
- A local importer/parallel distributor where permitted
Pharmacy supply chain pattern
Retail/wholesale supply generally routes:
- Through national wholesalers tied to the brand owner’s distribution network, then
- Through pharmacy wholesalers and individual dispensers
Are there multiple manufacturers for Premasol 10% in plastic container?
Featured snippet answer: Yes. For branded pharmaceuticals packaged in plastic containers, multiple manufacturing sites can exist across jurisdictions, including contract manufacturers.
Why multiple suppliers exist even with one brand
Multiple suppliers show up when:
- The product is registered in several countries with different MA holders
- Local fill-finish requirements exist for plastics and labeling
- Supply continuity is managed via alternate manufacturing sites
What are the plastic container supply constraints for Premasol 10%?
Featured snippet answer: Plastic-container supply depends on container-system availability, closure compatibility, and regulatory qualification of the container-contact materials.
Container-system variables that create sourcing risk
- Plastic film or polymer specification used in the container system
- Seals/closures and their extractables/leachables profiles
- Compatibility with the 10% formulation (chemical and adsorption effects)
- Sterilization approach and packaging validation (if sterile)
- Lead times for container manufacturing and filling-line slotting
What alternative suppliers exist if Premasol 10% plastic containers are constrained?
Featured snippet answer: Alternative sources typically come from other fill-finish sites qualified for the same container system or from the same marketing authorization holder using alternate contract manufacturers.
Common mitigation paths
- Switch to an alternate qualified manufacturing/packaging site
- Use alternate packaging presentation that still meets labeled product specs
- Allocate supply via distributor-led scheduling until the container system backlog clears
How does supplier selection impact regulatory status and batch release?
Featured snippet answer: Supplier changes are limited by regulatory comparability and batch-release documentation for the labeled strength and container system.
Key release and comparability artifacts usually required
- Site-level GMP compliance evidence
- Container qualification for the exact plastic contact system
- Stability bridging and validated manufacturing controls
- Batch documentation linking drug substance lot and packaging components
Key Takeaways
- Premasol 10% in plastic container is supplied through a label holder or authorized distributor plus one or more manufacturing and fill-finish suppliers.
- “Plastic container” adds a separate sourcing axis: container-system materials, closures, and qualification can constrain supply.
- Supplier continuity is usually managed through alternate qualified manufacturing sites and pre-approved container configurations tied to regulatory filings.
FAQs
- How can I identify the manufacturer of record for Premasol 10% on the label?
- Do plastic container suppliers differ across countries for the same Premasol 10% strength?
- What packaging changes typically require regulatory notification or prior approval?
- How do importers structure supply risk for plastic-container medicines during shortages?
- What documentation is most important when switching Premasol 10% suppliers for hospital procurement?
References
- No sources were provided in the prompt.
